Navigation Links
New wonder drug could treat blindness

Swiss drug maker Novartis has developed a drug that could treat blindness by combating the wet form of a condition called age-related// macular degeneration (AMD).

AMD usually affects people above 60 years of age and the wet form progresses quickly and can cause blindness.

The drug called Lucentis was tried on 716 patients in the US who received monthly injections of the drug into the affected eye over a two-year period.

One-third experienced a "marked improvement" in vision, enabling them to read more lines on an eye chart than before and return to abandoned hobbies, reported the online edition of Daily mail.

It is the first time a treatment for wet AMD has been found to significantly improve vision in large-scale clinical trials, said the study published in the New England Journal of Medicine.

Lucentis targets abnormal blood vessels that grow behind the eyeball. These vessels can leak and cause damage to parts of the eye responsible for central vision.

The drug, which is also known by its generic name Ranibizumab, has not yet been priced in Britain.

But in the US it costs around $2,000 a treatment. The drug is due to be licensed in Britain by the end of the year.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Butterbur does wonders
2. Cancer wonder drug will not be a slip between the cup and the lip!
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... , ... The Case Management Society of America (CMSA) will install six new ... membership has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on ... Advisory position has also been added to the BOD, per an appointment made by ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... Foothill Ranch, California (PRWEB) , ... March 27, 2017 , ... ... company’s commitment to its customers. First National Capital has added 10 new sales professionals ... to grow its sales positions by 15 additional new hires over the course of ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce the ... subjects. The ELITE DXA has an active scan window, which is more than double ... fit in the scan area could not undergo an accurate total body bone density or ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... -- A new survey from the American Association ... Program (CBP) significantly reduced beneficiary choice and access to ... forces beneficiaries to switch to unfamiliar or unsuitable testing ... AADE,s survey is the latest in a continuous ... the inherent problems with the CBP. Last year, a ...
(Date:3/27/2017)... YORK , March 27, 2017 FinancialBuzz.com ... Based ... adult use in states where cannabis is legal will generate $655 ... million will be from cannabis specific taxes, such as ... $96 million will be earned from state sales taxes that are ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
Breaking Medicine Technology: